Acadia To Open New Comprehensive Treatment Center in Delavan, Wisconsin

Acadia Healthcare Company, Inc. announces the upcoming opening of its Delavan, Wisconsin, Comprehensive Treatment Center (CTC) facility which will provide treatment for people seeking recovery from opioid use disorder (OUD) beginning in early December.

The Delavan CTC located at 1807 E. Geneva Street, Suite A, Delavan, Wisconsin, will serve patients seven days per week and will provide industry-leading medication-assisted treatment (MAT) services, including individual and group counseling, and FDA-approved medications such as methadone, suboxone, and vivitrol. The clinic will accept those seeking treatment with Medicare, Medicaid, Veterans Affairs, commercial and self-pay insurance.

“Acadia is committed to expanding access to care. With the new Delavan Medication Unit CTC, our team brings voluntary access to life-saving opioid use care to Southeastern Wisconsin,” said Jacob Cooper, CTC Group President. “Our long-term commitment to helping communities provide high-quality, effective treatment for illicit opioid use creates positive outcomes for patients through our proven care model which prioritizes personalized treatment strategies. At Acadia, we strongly believe that every patient who struggles with OUD should be able to access and stay in long-term recovery, and that treatment options should be individualized to the patient.”

Acadia’s MAT programs combine behavioral therapy and medication to treat opioid use disorders. Comprehensive Treatment Center (CTC) facilities provide a range of comprehensive substance abuse treatment support services that include medical, counseling, vocational, educational and other treatment services to help patients progress on a path to sustained recovery. Behavioral therapies are delivered in an array of models that may include individual and group therapy, intensive outpatient, outpatient, partial hospitalization/day treatment, road to recovery and other programs.

Acadia’s network of CTCs recently received validation from CARF International, one of the primary accrediting bodies for opioid addiction treatment programs, with scores in the 99th percentile across 13 measures of quality and performance. These scores demonstrate that the care provided in our programs exceeds the standards of quality opioid addiction treatment.

Acadia operates the largest opioid treatment program network in Wisconsin, now with 15 locations. The Company’s CTC division now operates 165 brick-and-mortar locations treating over 72,500 patients daily across 33 states nationwide.

Please visit https://www.ctcprograms.com for more information.